These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38634734)

  • 1. Developmental stage and infection status may affect drug distribution in the prostate of rats.
    Xu Z; Sun L; Yin C; Wu H; Wang X; Yang Y; Wang Z
    Xenobiotica; 2024 May; 54(5):248-256. PubMed ID: 38634734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.
    Hurtado FK; Weber B; Derendorf H; Hochhaus G; Dalla Costa T
    Antimicrob Agents Chemother; 2014; 58(2):678-86. PubMed ID: 24217697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-high performance liquid chromatographic determination of levofloxacin in human plasma and prostate tissue with use of experimental design optimization procedures.
    Szerkus O; Jacyna J; Wiczling P; Gibas A; Sieczkowski M; Siluk D; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():48-59. PubMed ID: 27423043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.
    Zimmermann ES; Laureano JV; Dos Santos CN; Schmidt S; Lagishetty CV; de Castro WV; Dalla Costa T
    Antimicrob Agents Chemother; 2016 Feb; 60(2):946-54. PubMed ID: 26621623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamsulosin alters levofloxacin pharmacokinetics in prostates derived from rats with acute bacterial prostatitis.
    Qin GD; Xiao MZ; Zhou YD; Yang J; He HX; He Y; Zeng Y
    Asian J Androl; 2013 Mar; 15(2):254-60. PubMed ID: 23353720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats.
    Shinmachi K; Takahashi Y; Kaneuji Y; Kawamura R; Kohama K; Hieda Y; Goromaru T; Eto S; Murakami T; Maeda Y
    Pharmazie; 2020 Nov; 75(11):554-558. PubMed ID: 33239128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the pharmacokinetics and tissue distribution of levofloxacin in humans based on an extrapolated PBPK model.
    Zhu L; Zhang Y; Yang J; Wang Y; Zhang J; Zhao Y; Dong W
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):395-402. PubMed ID: 25753830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin.
    Drusano GL; Preston SL; Van Guilder M; North D; Gombert M; Oefelein M; Boccumini L; Weisinger B; Corrado M; Kahn J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2046-51. PubMed ID: 10898674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers.
    Lee HK; DeVito V; Vercelli C; Tramuta C; Nebbia P; Re G; Kovalenko K; Giorgi M
    Res Vet Sci; 2017 Jun; 112():26-33. PubMed ID: 28113087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of levofloxacin after single intravenous and oral administration, and its interaction with sucralfate in mixed-breed dogs.
    Urzúa N; Messina MJ; Caverzan M; Prieto G; Lüders C; Errecalde C
    Xenobiotica; 2020 Dec; 50(12):1490-1493. PubMed ID: 32628058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary pharmacokinetics of levofloxacin in rats after aerosolization of immediate-release chitosan or sustained-release PLGA microspheres.
    Gaspar MC; Grégoire N; Sousa JJ; Pais AA; Lamarche I; Gobin P; Olivier JC; Marchand S; Couet W
    Eur J Pharm Sci; 2016 Oct; 93():184-91. PubMed ID: 27531420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands.
    Mase SR; Jereb JA; Gonzalez D; Martin F; Daley CL; Fred D; Loeffler AM; Menon LR; Bamrah Morris S; Brostrom R; Chorba T; Peloquin CA
    Pediatr Infect Dis J; 2016 Apr; 35(4):414-21. PubMed ID: 26658531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of levofloxacin in non-lactating goats and evaluation of drug effects on resistance in coliform rectal flora.
    Vercelli C; Łebkowska-Wieruszewska B; Barbero R; Lisowski A; Re G; Giorgi M
    Res Vet Sci; 2020 Dec; 133():283-288. PubMed ID: 33039880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics and Pharmacodynamics Modeling of Oral Levofloxacin.
    Jaruratanasirikul S; Jaspattananon A; Wongpoowarak W; Nawakitrangsan M; Thengyai S; Samaeng M
    J Med Assoc Thai; 2018 Aug; 99(8):886-92. PubMed ID: 29947489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust HPLC-MS/MS method for levofloxacin and ciprofloxacin determination in human prostate tissue.
    Szerkus O; Jacyna J; Gibas A; Sieczkowski M; Siluk D; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2017 Jan; 132():173-183. PubMed ID: 27744176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of hemiacetal esterified levofloxacin to prevent chelation with metal-containing drugs.
    Otori T; Matzno S; Kawase A; Iwaki M; Kimachi T; Nishiwaki K; Figoni WC; Tominaga R; Asahide M; Nishikata M; Ishii Y; Matsuyama K
    J Pharm Pharmacol; 2016 Dec; 68(12):1527-1534. PubMed ID: 27774590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced penetration of moxifloxacin into rat prostate tissue evidenced by microdialysis.
    K Hurtado F; Laureano JV; de A Lock G; Derendorf H; Dalla Costa T
    Int J Antimicrob Agents; 2014 Oct; 44(4):327-33. PubMed ID: 25218157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blood-prostate barrier: an obstacle to drug delivery into the prostate.
    Mou Y; Cao M; Zhang D
    Curr Drug Deliv; 2023 Aug; ():. PubMed ID: 37550915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (
    Sitovs A; Voiko L; Kustovs D; Kovalcuka L; Bandere D; Purvina S; Giorgi M
    J Vet Sci; 2020 Mar; 21(2):e32. PubMed ID: 32233138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves.
    Dumka VK
    J Vet Sci; 2007 Dec; 8(4):357-60. PubMed ID: 17993749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.